The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy in the BB/Wor-rat

<table>Longitudinal measurements of thermal
hyperalgesia in type 1 BB/Wor-rats without and with C-peptide replacement from
onset of diabetes compared to duration- and hyperglycemia-matched type 2
BBZDR/Wor-rats and age-matched control rats. 
Note more severe hyperalgesia in type 1 as compared to type 2 rats and
with partial but significant prevention in C-peptide treated rats [<a href="/journals/jdr/2008/230458/#B48">48</a>, <a href="/journals/jdr/2008/230458/#B49">49</a>].</table>

Journal of Diabetes Research

fig3

Figure 3

Figure 3: The Effects of C-peptide on Type 1 Diabetic Polyneuropathies and Encephalopathy in the BB/Wor-rat 